In the first of a series, columnist Joe MacDonald reflects on the birth of his oldest son, who hadn't yet been diagnosed with hemophilia.

Encouraged by the results of her most recent bone density scan, columnist G Shellye Horowitz pauses to celebrate the small ...

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

A caregiver needs respite from the duties of watching over a chronically ill patient, columnist Cazandra Campos-MacDonald writes.

Successful immune tolerance induction (ITI) in hemophilia A patients with inhibitors led to lower treatment costs, a study ...

Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...

Early diagnosis allows for timely preventive treatment and reduces the need for intensive factor replacement therapy in ...

Columnist G Shellye Horowitz chats with four women about their struggles to obtain a von Willebrand disease diagnosis.

Columnist Alliah Czarielle says her husband, Jared, adapts to whatever hemophilia and epilepsy throw his way. Being present is the core.

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

Jivi (damoctocog alfa pegol) has received approval from the U.S. Food and Drug Administration (FDA) that now extends to children with hemophilia A as young as 7 years old. Jivi had previously been ...

Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.